Enricoso, Maria B.

HRN: 06-71-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/06/2026
06/12/2026
IV
1.5gm
Q8
SSTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines